Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022-Reference-Cited by-同舟云学术

Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022

Published:2023-05-01 Issue:5 Volume:30 Page:558-586
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Harada-Shiba Mariko¹,Arai Hidenori²,Ohmura Hirotoshi³,Okazaki Hiroaki⁴,Sugiyama Daisuke⁵,Tada Hayato⁶,Dobashi Kazushige⁷,Matsuki Kota⁸,Minamino Tetsuo⁹,Yamashita Shizuya¹⁰,Yokote Koutaro¹¹

Affiliation:

1. Cardiovascular Center, Osaka Medical and Pharmaceutical University

2. National Center for Geriatrics and Gerontology

3. Department of Cardiovascular Biology and Medicine, Juntendo University, School of Medicine

4. Division of Endocrinology and Metabolism, Department of Internal Medicine, Jichi Medical University

5. Faculty of Nursing And Medical Care, Keio University

6. Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine

7. Department of Pediatrics, School of Medicine, University of Yamanashi

8. Department of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine

9. Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University

10. Department of Cardiology, Rinku General Medical Center

11. Department of Endocrinology, Hematology and Gerontology, Chiba University Graduate School of Medicine

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/30/5/30_CR005/_pdf

Reference120 articles.

1. 1) Tada H, Hori M, Matsuki K, Ogura M, Nohara A, Kawashiri MA, Harada-Shiba M: Achilles Tendon Thickness Assessed by X-ray Predicting a Pathogenic Mutation in Familial Hypercholesterolemia Gene. J Atheroscler Thromb, 2022; 29: 816-824

2. 2) Harada-Shiba M, Ohtake A, Sugiyama D, Tada H, Dobashi K, Matsuki K, Minamino T, Yamashita S, Yamamoto Y: Guidelines for the Diagnosis and Treatment of Pediatric Familial Hypercholesterolemia 2022. J Atheroscler Thromb, 2023; 30: 531-557

3. 3) Mabuchi H, Nohara A, Noguchi T, Kobayashi J, Kawashiri MA, Tada H, Nakanishi C, Mori M, Yamagishi M, Inazu A, Koizumi J: Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan. Atherosclerosis, 2011; 214: 404-407

4. 4) Akioyamen LE, Genest J, Shan SD, Reel RL, Albaum JM, Chu A, Tu JV: Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis. BMJ Open, 2017; 7: e016461

5. 5) Beheshti SO, Madsen CM, Varbo A, Nordestgaard BG: Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects. J Am Coll Cardiol, 2020; 75: 2553-2566

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potentials of artificial intelligence in familial hypercholesterolemia: Advances in screening, diagnosis, and risk stratification for early intervention and treatment;International Journal of Cardiology;2024-10

2. Characteristics, Physiopathology and Management of Dyslipidemias in Pregnancy: A Narrative Review;Nutrients;2024-09-01

3. Efficacy of Alirocumab, Evolocumab, and Inclisiran in Patients with Hypercholesterolemia at Increased Cardiovascular Risk;Medicina;2024-07-12

4. Japanese Diagnostic Criteria for Pediatric Familial Hypercholesterolemia 2022;Journal of Atherosclerosis and Thrombosis;2024-07-01

5. Assessment Timings of Polygenic Risk Score for Atherosclerotic Cardiovascular Disease;Journal of Atherosclerosis and Thrombosis;2024-07-01